ISRCTN99691973已完成未知
Prioritising and optimising multiple medications in elderly multi-morbid patients in general practice: a pilot open-label two-arm cluster-randomised controlled trial
German Federal Ministry of Education and Research (Bundesministerium Fur Bildung und Forschung [BMBF]) (Germany)0 个研究点目标入组 100 人开始时间: 2009年7月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
2016 results in: http://www.ncbi.nlm.nih.gov/pubmed/27456328
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. At least 65 years old, either sex
- •2. At least three chronic diseases
- •3. At least five continuous prescriptions
- •4. At least one practice visit during the last quarter
- •5. Written informed consent
- •6. Ability to fill out a questionnaire and participate in a telephone interview
- •1. Practice serves members of the German statutory health insurance system
- •2. GP practice
- •3. Physician is specialised in general practice or internal medicine, or without specialisation
- •4. Internet access
- •5. Availability of a practice nurse who can participate in the study
排除标准
- •1. Life expectancy of less than six months
- •2. Drug addiction problems
- •3. Cognitive impairment (Mini Mental State Examination [MMSE] score less than 26)
- •4. Emotional stress that would prevent participation in the study
- •5. Participation in a clinical trial within the last 30 days
研究者
相似试验
已完成
不适用
Prioritising and optimising multi-medication in multimorbidityISRCTN99526053Johann Wolfgang Goethe University (Germany)502
已完成
不适用
Prioritising and Optimising Multi-medication in MultimorbidityChronic DiseaseNCT01171339Goethe University505
已完成
不适用
A collaborative approach to optimise medication use for older people in nursing homes: a cluster controlled trialOptimization of medicationISRCTN66138978KU Leuven1,804
已完成
不适用
The 3D Study: improving whole person careTopic: Primary Care Research Network for EnglandSubtopic: Not AssignedDisease: All DiseasesISRCTN06180958niversity of Bristol (UK)1,383
已完成
不适用
Optimising individualised prescribing with therapeutic drug Monitoring for Antipsychotics (OptIMA) 2: clinical pilot study of antipsychotic drug level monitoringSchizophreniaISRCTN71305621Institute of Psychiatry, Kings College London (UK)32